![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Found 19 studies with search of: | "ZIOPHARM" [Exact] |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Active, not recruiting |
Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors
|
||||
2 | Completed |
A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma
|
||||
3 | Suspended |
Study of Oral Palifosfamide Tris in Solid Tumors
|
||||
4 | Active, not recruiting |
Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers
|
||||
5 | Active, not recruiting |
Phase I Study of Oral ZIO-101 in Advanced Solid Tumors
|
||||
6 | Active, not recruiting |
A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer
|
||||
7 | Active, not recruiting |
Phase I Study of Indibulin in Patients With Solid Tumors
|
||||
8 | Active, not recruiting |
A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b
|
||||
9 | Active, not recruiting |
A Phase I Trial of ZIO-101 in Hematologic Cancers
|
||||
10 | Active, not recruiting |
Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas
|
||||
11 | Recruiting |
Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors
|
||||
12 | Recruiting |
A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-Tissue Sarcoma
|
||||
13 | Active, not recruiting |
Study of ZIO-201 in Advanced Sarcoma
|
||||
14 | Recruiting |
Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors
|
||||
15 | Recruiting |
Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans
|
||||
16 | Recruiting |
Phase I Study in Advanced Solid Tumors
|
||||
17 | Active, not recruiting |
A Phase I Trial of ZIO-101 in Solid Tumors
|
||||
18 | Active, not recruiting |
Study of ZIO-101 in Multiple Myeloma
|
||||
19 | Completed |
Phase I Trial of ZIO-101 in Patients With Solid Tumors
|